Mind Medicine Inc [MNMD] stock prices are up 6.21% to $7.01 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MNMD shares have gain 8.68% over the last week, with a monthly amount glided 21.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mind Medicine Inc [NASDAQ: MNMD] stock has seen the most recent analyst activity on January 28, 2025, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $23. Previously, Chardan Capital Markets started tracking the stock with Buy rating on December 20, 2024, and set its price target to $20. ROTH MKM started tracking the stock assigning a Buy rating and suggested a price target of $36 on July 24, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $27 as its price target on May 29, 2024. Leerink Partners started tracking with a Outperform rating for this stock on April 15, 2024, and assigned it a price target of $20. In a note dated December 05, 2023, Canaccord Genuity initiated an Buy rating and provided a target price of $9 on this stock.
The stock price of Mind Medicine Inc [MNMD] has been fluctuating between $4.70 and $10.44 over the past year. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Mind Medicine Inc [NASDAQ: MNMD] shares were valued at $7.01 at the most recent close of the market. An investor can expect a potential return of 128.25% based on the average MNMD price forecast.
Analyzing the MNMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.33 and Total Capital is -0.47. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Mind Medicine Inc [NASDAQ:MNMD]’s Current Ratio is 7.27. In addition, the Quick Ratio stands at 7.27 and the Cash Ratio stands at 2.72.
Transactions by insiders
Recent insider trading involved Barrow Robert, Chief Executive Officer, that happened on Mar 25 ’25 when 21208.0 shares were sold. Chief Medical Officer, Karlin Daniel completed a deal on Mar 25 ’25 to sell 6836.0 shares. Meanwhile, Chief Legal Officer Sullivan Mark sold 6576.0 shares on Mar 25 ’25.
